Sarcoidosis classification

Jump to navigation Jump to search

Sarcoidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sarcoidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sarcoidosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sarcoidosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sarcoidosis classification

CDC on Sarcoidosis classification

Sarcoidosis classification in the news

Blogs on Sarcoidosis classification

Directions to Hospitals Treating Sarcoidosis

Risk calculators and risk factors for Sarcoidosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh M.D.

Overview

There is no universally accepted classification system for sarcoidosis according to our knowledge, but in some references sarcoidosis is classified regarding the organ system involved. The lung is involved in 90% of patients diagnosed with sarcoidosis, thus sarcoidosis is generally classified into pulmonary sarcoidosis and extra-pulmonary sarcoidosis.

Classification

Scadding proposed a scoring system regarding the chest radiograph for pulmonary sarcoidosis in 1961.

stage 1: Hilar adenopathy alone

stage 2: Hilar adenopathy plus lung infiltrates

stage 3: Lung infiltrates alone

stage 4: Fibrosis[1]

Scadding's classification correlates with prognosis. Individuals with stage 1 disease, have a 80% chance of resolution of hilar adenopathy and those with stage 3 disease, have less than 30% chance of CXR resolution. The limitations of Scadding's scoring system include: 1. It does not characterize extra-pulmonary sarcoidosis 2. There is a significant variability in staging even among experienced radiologists[2].



References

  1. Scadding JG: Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. British medical journal 1961, 2(5261):1165-1172.
  2. Baughman RP, Shipley R, Desai S, Drent M, Judson MA, Costabel U, du Bois RM, Kavuru M, Schlenker-Herceg R, Flavin S et al: Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009, 136(2):526-53

Template:WH Template:WS